Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Bitterman Robert J, Director. Insider active across 1 company, notably Phio Pharmaceuticals Corp.. In total, 27 filings have been logged. Split: 19 buys · 0 sell. Total volume traded: €52k. Activity tracked since 15 February 2022. The latest transaction was disclosed on 18 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Bitterman Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 shares@ US$1,750.009.1% of flowSeries D Preferred Stock, $0.0001 par valueSEC:0001209191-22-057333:0
Canonical exit: 14 Feb 2023 (T+90)
25 of 27 declarations
About Bitterman Robert J
Bitterman Robert J is Administrateur and serves at Phio Pharmaceuticals Corp. as Chairman, Pres. & CEO. He has filed 26 forms in total, and across the 26 sampled filings from 2022-02-16 to 2026-06-29, the transactions are acquisitions with total purchases of EUR 42863 and no sales reported.